Alnylam Pharmaceuticals
ALNY
#647
Rank
โ‚ฌ26.49 B
Marketcap
204,72ย โ‚ฌ
Share price
0.89%
Change (1 day)
47.28%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: โ‚ฌ26.49 Billion

As of April 2025 Alnylam Pharmaceuticals has a market cap of โ‚ฌ26.49 Billion. This makes Alnylam Pharmaceuticals the world's 647th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ26.49 B-10.17%
2024โ‚ฌ29.49 B35.74%
2023โ‚ฌ21.72 B-20.28%
2022โ‚ฌ27.25 B52.2%
2021โ‚ฌ17.90 B45.88%
2020โ‚ฌ12.27 B6.44%
2019โ‚ฌ11.53 B78.87%
2018โ‚ฌ6.44 B-38.59%
2017โ‚ฌ10.50 B243.79%
2016โ‚ฌ3.05 B-58.31%
2015โ‚ฌ7.32 B18.98%
2014โ‚ฌ6.15 B107.47%
2013โ‚ฌ2.96 B309.81%
2012โ‚ฌ0.72 B170.08%
2011โ‚ฌ0.26 B-14.57%
2010โ‚ฌ0.31 B-39%
2009โ‚ฌ0.51 B-29.77%
2008โ‚ฌ0.73 B-9.78%
2007โ‚ฌ0.81 B35.14%
2006โ‚ฌ0.60 B176.3%
2005โ‚ฌ0.21 B104.8%
2004โ‚ฌ0.10 B

End of Day market cap according to different sources

On Apr 15th, 2025 the market cap of Alnylam Pharmaceuticals was reported to be:

โ‚ฌ26.26 Billion
by Nasdaq info icon info icon
โ‚ฌ26.26 Billion
by CompaniesMarketCap info icon info icon
โ‚ฌ26.26 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚ฌ1.38 B-94.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ53.10 B 100.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.60 B-82.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.99 B-96.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.11 B-99.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ192.31 B 625.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ112.78 B 325.67%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ13.56 B-48.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel